Trial NCT00674557

View at ClinicalTrials.gov 
Org. Study IDs: CRUK-CR0207-22
Secondary IDs: 2007-005752-16 CDR0000595074 EU-20850

Last trial update was posted on 2013-07-10

MeSH Interventions

Exemestane Tetrathiomolybdate

MeSH Conditions

Breast Neoplasms

Other Conditions

Breast Cancer

Stopping Reasons

Withdrawn as the clinical development of ATN-224 was terminated by the drug company who was providing ATN-224 for the study

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID